Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and ...

Toronto, Ontario--(Newsfile Corp. - March 24, 2025) - Optimind Pharma Corp. (CSE: OMND) (the "Optimind" or the "Company") announces that it has entered into a non-binding letter of intent dated ...

Anixa Biosciences signed a letter of intent with VERDI Solutions to develop AI-powered personalized and off-the-shelf cancer ...

Predictiv AI will acquire all issued and outstanding shares in the capital of both Shift and HouseStack (the "Target Shares") in exchange for 82.5% (previously 70%) of the PAI Shares immediately ...

Proposed acquisition would bring advanced space technologies and deep-space navigation expertise into ParaZero’s innovation portfolio TEL AVIV, ...

Founded in 2019, QumulusAI is a fully integrated AI infrastructure solution with ... termination of the Letter of Intent or its exclusivity; Vincerx’s capital requirements and cash runway ...

Anixa Biosciences (ANIX) has entered into a letter of intent with Verdi Solutions to develop personalized and off-the-shelf peptide vaccines ...

TORONTO, ON / ACCESS Newswire / March 18, 2025 / Predictiv AI Inc. (TSXVNEX:PAI.H)(OTC PINK:INOTF)(FSE:71TA) ("Predictiv AI", "PAI" or the "Company")announces that further to the news releases of Augu ...

Vincerx Pharma, Inc. announced a non-binding letter of intent to merge with Global Digital Holdings Inc., operating as QumulusAI, a high-performance computing company focused on AI. The merger ...

Predictiv AI will acquire all issued and outstanding shares in the capital of both Shift and HouseStack (the "Target Shares") in exchange for 82.5% (previously 70%) of the PAI Shares immediately prior ...